EGFR and non-small cell lung carcinoma: Previous studies revealed that EGFR activation in NSCLC cells could release SHC‐binging protein 1 (SHCBP1) from SHC1, which subsequently transferred to the nucleus and advanced the trans‐activation of β‐catenin, thus leading to the development of stemness and malignant progression in NSCLC cells.55